课题基金 / 基金详情

ROLE OF CATHEPSINS S, L AND B IN THE TYPE 1 DIABETES

ROLE OF CATHEPSINS S, L AND B IN THE TYPE 1 DIABETES
组织蛋白酶 S、L 和 B 在 1 型糖尿病中的作用
批准号:
6666916
负责人:
Alexander Y Rudensky
金额:
$37.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2005-08-31

项目摘要

项目成果

Alexander Y Rudensky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autoreactive MHC class II-reactive CD4 T lymphocytes play a critical role in the pathogenesis of Type 1 diabetes. Lysosomal cysteine proteinases, cathepsin (Cat) S, L, and B are implicated in antigen processing and presentation by MHC class II molecules to CD4 T cells. These enzymes participate in the proteolytic degradation of MHC class II associated invariant chain and in generation of antigenic peptides from self and foreign antigens. In this proposal, we will study non-obese diabetes prone (NOD) mice, which show MHC-dependent susceptibility to Type 1 diabetes analogous to that seen in humans. We have generated NOD mice deficient in Cat S, L or B by breeding the corresponding knockout mice onto the NOD background. Preliminary studies suggest that incidence of diabetes is significantly reduced in Cat S and B null mice as compared to heterozygous littermates. Reduced disease in Cat deficient mice can be due to: diminished antigen presentation by MHC class II molecules; diminished non-specific inflammation mediated by macrophages; reduced development of autoreactive CD4 T cells; increased activity of suppressor T cells; reduced autoantigen production in the islet _-cells; increased resistance of islet a cells to apoptosis. In this proposal, we will test all these hypotheses by investigating the role of cat B, S and L in spontaneous type I diabetes in the following specific Aims: 1) to characterize disease progression, MHC class II antigen processing and presentation, and CD4 T cell development in Cat-deficient and wild type control NOD mice; 2) to determine cellular mechanisms responsible for reduced diabetes in cathepsin-deficient NOD mice. This work will contribute to our understanding of the role of cathepsins in MHC class II antigen presentation, and provide new targets for downmodulating the immune responses leading to Type 1 diabetes.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1373/clinchem.2010.144329
发表时间: 2010-09
期刊: Clinical chemistry
影响因子: 9.3
作者: [Janik DK, Lindau-Shepard B, Comeau AM, Pass KA]
通讯作者: Pass KA
Improved immunoassay for the detection of severe combined immunodeficiency.
改进的免疫测定法用于检测严重联合免疫缺陷。
DOI: 10.1373/clinchem.2011.162263
发表时间: 2011
期刊: Clinical chemistry
影响因子: 9.3
作者: [Janik,DavidK, Lindau-Shepard,Barbara, Nørgaard-Pedersen,Bent, Heilmann,Carsten, Pass,KennethA]
通讯作者: Pass,KennethA
DOI: 10.2217/bmm.12.108
发表时间: 2013-04
期刊: Biomarkers in medicine
影响因子: 2.2
作者: [Mizejewski GJ, Lindau-Shepard B, Pass KA]
通讯作者: Pass KA
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
  • 批准号:
    10525193
  • 项目类别:
  • 资助金额:
    $78.77万
  • 财政年份:
    2022
  • 负责人:
    Alexander Y Rudensky
  • 依托单位:
Project II: Immune regulatory circuits in primary colon cancer and lymph node and liver metastases
  • 批准号:
    10705782
  • 项目类别:
  • 资助金额:
    $73.46万
  • 财政年份:
    2022
  • 负责人:
    Alexander Y Rudensky
  • 依托单位:
The tumor ecosystem in cancer progression and immunotherapeutic response
  • 批准号:
    9980809
  • 项目类别:
  • 资助金额:
    $63.87万
  • 财政年份:
    2016
  • 负责人:
    Alexander Y Rudensky
  • 依托单位:
MOLECULAR MECHANISMS OF REGULATORY T CELL DEVELOPMENT
  • 批准号:
    7437301
  • 项目类别:
  • 资助金额:
    $27.23万
  • 财政年份:
    2004
  • 负责人:
    Alexander Y Rudensky
  • 依托单位:
海外基金